Enterprise League logo
Cancer Advances Logo

Cancer Advances

Durham, United States (US) · Health and Medical

Do your work at Cancer Advances?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

Cancer Advances is a Durham, North Carolina-based biotechnology company focused on developing novel cancer therapeutics.

We are dedicated to pioneering new medicines and redefining possibilities for cancer patients through the development of PAS (Polyclonal Antibody Stimulator), a vaccine designed to stimulate the immune system to produce endogenous polyclonal antibodies against gastrin, offering a safer alternative to traditional therapies.

Our core expertise lies in leveraging intellectual property acquired from Aphton Corporation and Receptor Biologix, built upon research originating from the University of Nottingham. We are currently exploring synergies between PAS and other treatment classes to enhance patient outcomes.

Cancer Advances holds over 100 patents related to PAS and actively pursues a robust trademark strategy, solidifying our position as a leader in innovative cancer vaccine development.

Most teams do this before shortlisting


Contact Details

info@canceradvancesinc.com

Durham, United States (US), 4364 S Alston Ave

Founded

2008

Company Type

Private Limited Company

Employees

10-20

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after Cancer Advances

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.